{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:20:49Z","timestamp":1778253649018,"version":"3.51.4"},"reference-count":44,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.3892\/mmr.2016.5095","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T17:18:28Z","timestamp":1460135908000},"page":"4549-4560","source":"Crossref","is-referenced-by-count":48,"title":["Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone"],"prefix":"10.3892","volume":"13","author":[{"given":"ALBERTO IVAN","family":"SALIDO-GUADARRAMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JORGE GUSTAVO","family":"MORALES-MONTOR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CLAUDIA","family":"RANGEL-ESCARE\u00d1O","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELIZABETH","family":"LANGLEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OSCAR","family":"PERALTA-ZARAGOZA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOSE LUIS CRUZ","family":"COLIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURICIO","family":"RODRIGUEZ-DORANTES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"key20180108024922_b1-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20180108024922_b2-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcb.10747","article-title":"Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment","volume":"91","author":"De Marzo","year":"2004","journal-title":"J Cell Biochem"},{"key":"key20180108024922_b3-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"key20180108024922_b4-mmr-13-06-4549","first-page":"44","article-title":"Clinical utility of prostate carcinoma molecular diagnostic tests","volume":"10","author":"Shappell","year":"2008","journal-title":"Rev Urol"},{"key":"key20180108024922_b5-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.eururo.2012.05.072","article-title":"Active surveillance for prostate cancer: A systematic review of the literature","volume":"62","author":"Dall'Era","year":"2012","journal-title":"Eur Urol"},{"key":"key20180108024922_b6-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urolonc.2013.09.017","article-title":"Prostate cancer biomarkers: An update","volume":"32","author":"Romero Otero","year":"2014","journal-title":"Urol Oncol"},{"key":"key20180108024922_b7-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10456-015-9474-5","article-title":"Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer","volume":"18","author":"Mao","year":"2015","journal-title":"Angiogenesis"},{"key":"key20180108024922_b8-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/MCB.01395-06","article-title":"A microRNA signature of hypoxia","volume":"27","author":"Kulshreshtha","year":"2007","journal-title":"Mol Cell Biol"},{"key":"key20180108024922_b9-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"e113700","DOI":"10.1371\/journal.pone.0113700","article-title":"Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer","volume":"9","author":"Katz","year":"2014","journal-title":"PLoS One"},{"key":"key20180108024922_b10-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fonc.2014.00143","article-title":"Regulation of Metastasis by microRNAs in Ovarian Cancer","volume":"4","author":"Wang","year":"2014","journal-title":"Front Oncol"},{"key":"key20180108024922_b11-mmr-13-06-4549","first-page":"255","article-title":"Regulation of microRNAs in cancer metastasis","volume":"1845","author":"Bouyssou","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"key20180108024922_b12-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/onc.2013.54","article-title":"Roles of microRNAs during prostatic tumorigenesis and tumor progression","volume":"33","author":"Fang","year":"2014","journal-title":"Oncogene"},{"key":"key20180108024922_b13-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1158\/0008-5472.CAN-08-0144","article-title":"Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer","volume":"68","author":"Ambs","year":"2008","journal-title":"Cancer Res"},{"key":"key20180108024922_b14-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-07-0533","article-title":"MicroRNA expression profiling in prostate cancer","volume":"67","author":"Porkka","year":"2007","journal-title":"Cancer Res"},{"key":"key20180108024922_b15-mmr-13-06-4549","first-page":"1327","article-title":"MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer","volume":"7","author":"Salido-Guadarrama","year":"2014","journal-title":"Onco Targets Ther"},{"key":"key20180108024922_b16-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1158\/0008-5472.CAN-10-1229","article-title":"Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients","volume":"71","author":"Moltzahn","year":"2011","journal-title":"Cancer Res"},{"key":"key20180108024922_b17-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.25376","article-title":"Circulating miRNAs are correlated with tumor progression in prostate cancer","volume":"128","author":"Brase","year":"2011","journal-title":"Int J Cancer"},{"key":"key20180108024922_b18-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-09-0736","article-title":"Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection","volume":"15","author":"Park","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108024922_b19-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"e76994","DOI":"10.1371\/journal.pone.0076994","article-title":"MicroRNA profiling in prostate cancer-the diagnostic potential of urinary miR-205 and miR-214","volume":"8","author":"Srivastava","year":"2013","journal-title":"PLoS One"},{"key":"key20180108024922_b20-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"e91729","DOI":"10.1371\/journal.pone.0091729","article-title":"Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer","volume":"9","author":"Sapre","year":"2014","journal-title":"PLoS One"},{"key":"key20180108024922_b21-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12032-014-0413-x","article-title":"Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis","volume":"32","author":"Eissa","year":"2015","journal-title":"Med Oncol"},{"key":"key20180108024922_b22-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7150\/jca.6799","article-title":"Potential urinary miRNA biomarker candidates for the accurate detection of prostate cancer among benign prostatic hyperplasia patients","volume":"5","author":"Haj-Ahmad","year":"2014","journal-title":"J Cancer"},{"key":"key20180108024922_b23-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin Chem"},{"key":"key20180108024922_b24-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4161\/cc.26984","article-title":"miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration","volume":"13","author":"Lewis","year":"2014","journal-title":"Cell Cycle"},{"key":"key20180108024922_b25-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108024922_b26-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1186\/s12864-015-2199-4","article-title":"Incorporation of subject-level covariates in quantile normalization of miRNA data","volume":"16","author":"Suyundikov","year":"2015","journal-title":"BMC Genomics"},{"key":"key20180108024922_b27-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2012.09.033","article-title":"Contemporary role of systematic prostate biopsies: Indications, techniques, and implications for patient care","volume":"63","author":"Ukimura","year":"2013","journal-title":"Eur Urol"},{"key":"key20180108024922_b28-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000145883.01068.5f","article-title":"Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography","volume":"173","author":"Loeb","year":"2005","journal-title":"J Urol"},{"key":"key20180108024922_b29-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11934-011-0177-1","article-title":"Management of rising prostate-specific antigen after a negative biopsy","volume":"12","author":"Levy","year":"2011","journal-title":"Curr Urol Rep"},{"key":"key20180108024922_b30-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/pcan.2009.31","article-title":"Urine markers in monitoring for prostate cancer","volume":"13","author":"Jamaspishvili","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key20180108024922_b31-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"16.e17","DOI":"10.1016\/j.urolonc.2014.09.015","article-title":"Identification of cell-free microRNAs in the urine of patients with prostate cancer","volume":"33","author":"Korzeniewski","year":"2015","journal-title":"Urol Oncol"},{"key":"key20180108024922_b32-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1515\/cclm-2014-1000","article-title":"Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue","volume":"53","author":"Stephan","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"key20180108024922_b33-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4161\/cbt.27627","article-title":"Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: Potential effects on the tumor microenvironment","volume":"15","author":"Kim","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"key20180108024922_b34-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.bbagrm.2012.08.016","article-title":"Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells","volume":"1819","author":"Hessvik","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"key20180108024922_b35-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.ju.0000165568.76908.5c","article-title":"4-year prostate specific antigen progression and diagnosis of prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam","volume":"174","author":"Schr\u00f6der","year":"2005","journal-title":"J Urol"},{"key":"key20180108024922_b36-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2015.37","article-title":"Decision curve analysis","volume":"313","author":"Fitzgerald","year":"2015","journal-title":"JAMA"},{"key":"key20180108024922_b37-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.12.001","article-title":"Urine PCA3 and TMPRSS2: ERG using cancer-specific markers to detect cancer","volume":"65","author":"Tomlins","year":"2014","journal-title":"Eur Urol"},{"key":"key20180108024922_b38-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/pros.22563","article-title":"Urine TMPRSS2: ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer","volume":"73","author":"Cornu","year":"2013","journal-title":"Prostate"},{"key":"key20180108024922_b39-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2010.06.039","article-title":"Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: Exploring the value of PCA3 for a first-line diagnostic test","volume":"58","author":"Roobol","year":"2010","journal-title":"Eur Urol"},{"key":"key20180108024922_b40-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.urolonc.2011.07.002","article-title":"MicroRNA expression profiles in the progression of prostate cancer - from high-grade prostate intraepithelial neoplasia to metastasis","volume":"31","author":"Leite","year":"2013","journal-title":"Urol Oncol"},{"key":"key20180108024922_b41-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.juro.2010.10.035","article-title":"MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer","volume":"185","author":"Leite","year":"2011","journal-title":"J Urol"},{"key":"key20180108024922_b42-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"e69239","DOI":"10.1371\/journal.pone.0069239","article-title":"Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"key":"key20180108024922_b43-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108024922_b44-mmr-13-06-4549","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/onc.2012.131","article-title":"The miR-99 family regulates the DNA damage response through its target SNF2H","volume":"32","author":"Mueller","year":"2013","journal-title":"Oncogene"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.5095\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T23:59:20Z","timestamp":1515369560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.5095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,8]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,4,8]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.3892\/mmr.2016.5095"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.5095","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,8]]}}}